We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Prazosin hydrochloride capsules, USP 5mg (Granules Pharmaceuticals, USA)
Section 19A approved medicine
Prazosin hydrochloride capsules, USP 5mg (Granules Pharmaceuticals, USA)
Section 19A approval holder
Phero Pharma Pty Ltd ABN 96 673 730 231
Phone
02 9420 9199
Approved until
Status
Current
Medicines in short supply/unavailable
APO-PRAZOSIN prazosin (as hydrochloride) 5mg tablet blister pack - ARTG 73866
MINIPRESS prazosin 5 mg (as hydrochloride) tablet blister pack - ARTG 10758
MINIPRESS prazosin 5 mg (as hydrochloride) tablet blister pack - ARTG 10758
Indication(s)
In patients with hypertension.
Prazosin is indicated in the treatment of hypertension of varied aetiology and all grades of severity. It can be used as the initial and sole agent, or it may be employed in a treatment programme in conjunction with other antihypertensive agents.
Images
